Skip to main content
    U

    UFP Technologies Inc (UFPT)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $298.54
    -6.52 (-2.14%)

    Market Cap: $2.36B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    UFP Technologies Inc (UFPT) Earnings: Report Dates and Results

    Updated Nov 3, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    UFP Technologies (UFPT) is expected to report earnings on Feb 22, 2027. In the quarter ended Sep 30, 2026, UFP Technologies reported EPS of $2.88, above the $2.63 estimate. It beat the EPS estimate in each of the last 17 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    88%(35/40)
    Avg Surprise
    +18.20%
    Streak
    17 Q

    Upcoming Estimates

    Reports Feb 22, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$2.57
    Range$2.42 - $2.72
    6 analysts
    Revenue Consensus
    $167.47M
    Range$157.58M - $181.47M
    6 analysts
    Reports May 3, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$2.74
    Range$2.73 - $2.75
    2 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$2.69+1.9%
    60d ago$2.69+1.9%
    30d ago$2.69+1.9%
    7d ago$2.69+1.9%
    Current$2.74
    Revenue Consensus
    $166.71M
    Range$165.00M - $168.43M
    2 analysts

    Next Report

    UFPT has an expected report date of Feb 22, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 5.3% above the $2.44 reported for the quarter ended Dec 31, 2025.

    UFPT Earnings Call

    The latest UFPT earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, UFPT beat 35 and missed 5. Revenue for the quarter ended Sep 30, 2026 was $172.43M, up 11.6% from $154.56M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$2.88$2.63$2.57 - $2.78+9.51%Beat+20.5%40 up, 2 downNov 3, 2026$172.43M
    Jun 30, 2026$2.92$2.51$2.46 - $2.63+16.33%Beat+16.8%43 up, 1 downAug 3, 2026$173.96M
    Mar 31, 2026$2.48$2.31$2.18 - $2.38+7.36%Beat+0.4%40 up, 2 downMay 4, 2026$154.20M
    Dec 31, 2025$2.44$2.20$2.15 - $2.30+10.91%Beat-0.8%41 up, 3 downFeb 24, 2026$148.91M
    Sep 30, 2025$2.39$2.17$2.09 - $2.28+10.14%Beat0.0%40 up, 2 downNov 3, 2025$154.56M
    Jun 30, 2025$2.50$2.25$2.08 - $2.33+11.11%Beat+34.4%44 up, 0 downAug 4, 2025$151.18M
    Mar 31, 2025$2.47$2.01$1.83 - $2.11+22.89%Beat+48.8%40 up, 0 downMay 6, 2025$148.15M
    Dec 31, 2024$2.46$2.14$2.10 - $2.17+15.22%Beat+62.9%20 up, 1 downFeb 25, 2025$144.07M
    Sep 30, 2024$2.39$1.86$1.71 - $1.88+28.49%Beat+57.2%30 up, 0 downNov 5, 2024$145.16M
    Jun 30, 2024$1.86$1.54$1.50 - $1.55+20.78%Beat+18.5%30 up, 0 downJul 31, 2024$110.18M
    Mar 31, 2024$1.66$1.17$1.05 - $1.17+41.88%Beat+5.7%30 up, 0 downMay 1, 2024$105.01M
    Dec 31, 2023$1.51$1.14$1.12 - $1.15+32.46%Beat+37.3%20 up, 0 downFeb 21, 2024$101.50M
    Sep 30, 2023$1.52$1.49$1.49 - $1.49+2.01%Beat+55.1%10 up, 0 downNov 1, 2023$100.78M
    Jun 30, 2023$1.57$1.42$1.42 - $1.42+10.56%Beat+175.4%20 up, 0 downAug 1, 2023$100.04M
    Mar 31, 2023$1.57$1.12$0.96 - $1.12+40.18%Beat+118.1%20 up, 0 downMay 2, 2023$97.75M
    Dec 31, 2022$1.10$0.91$0.90 - $0.91+20.88%Beat+161.9%20 up, 0 downMar 7, 2023$91.24M
    Sep 30, 2022$0.98$0.91$0.91 - $0.98+7.69%Beat+92.2%20 up, 0 downNov 2, 2022$96.97M
    Jun 30, 2022$0.57$0.79$0.69 - $0.79-27.85%Miss-8.1%20 up, 0 downAug 2, 2022$94.34M
    Mar 31, 2022$0.72$0.45$0.45 - $0.45+60.00%Beat+30.9%10 up, 0 downMay 4, 2022$71.24M
    Dec 31, 2021$0.42$0.41$0.39 - $0.42+2.44%Beat-23.6%20 up, 0 downMar 8, 2022$56.34M
    Sep 30, 2021$0.51$0.59$0.57 - $0.61-13.56%Miss+27.5%20 up, 0 downNov 3, 2021$50.72M
    Jun 30, 2021$0.62$0.52$0.47 - $0.57+19.23%Beat+82.4%2N/AAug 3, 2021$50.66M
    Mar 31, 2021$0.55$0.36$0.33 - $0.39+52.78%Beat+5.8%2N/AMay 4, 2021$48.60M
    Dec 31, 2020$0.55$0.42$0.41 - $0.42+30.95%Beat-28.6%2N/AMar 4, 2021$45.15M
    Sep 30, 2020$0.40$0.32$0.32 - $0.32+25.00%Beat-46.7%1N/ANov 3, 2020$43.30M
    Jun 30, 2020$0.34$0.20$0.20 - $0.20+70.00%Beat-45.2%1N/AAug 4, 2020$42.64M
    Mar 31, 2020$0.52$0.54$0.54 - $0.54-3.70%Miss+4.0%1N/AMay 5, 2020$48.28M
    Dec 31, 2019$0.77$0.60$0.60 - $0.60+28.33%Beat+30.5%1N/AMar 4, 2020$50.26M
    Sep 30, 2019$0.75$0.56$0.56 - $0.56+33.93%Beat+33.9%1N/ANov 5, 2019$49.39M
    Jun 30, 2019$0.62$0.56$0.56 - $0.56+10.71%Beat+14.8%1N/AAug 6, 2019$51.40M
    Mar 31, 2019$0.50$0.40$0.40 - $0.40+25.00%Beat+108.3%1N/AMay 7, 2019$47.33M
    Dec 31, 2018$0.59$0.58$0.58 - $0.58+1.72%Beat+59.5%1N/AMar 6, 2019$50.70M
    Sep 30, 2018$0.56$0.55$0.55 - $0.55+1.82%Beat+143.5%1N/ANov 1, 2018$47.81M
    Jun 30, 2018$0.54$0.50$0.50 - $0.50+8.00%Beat+45.9%1N/AAug 2, 2018$49.02M
    Mar 31, 2018$0.24$0.16$0.16 - $0.16+50.00%Beat-20.0%1N/AMay 4, 2018$42.93M
    Dec 31, 2017$0.37$0.23$0.23 - $0.23+60.87%Beat+85.0%1N/AMar 1, 2018$37.22M
    Sep 30, 2017$0.23$0.36$0.36 - $0.36-36.11%Miss+4.5%1N/ANov 2, 2017$35.68M
    Jun 30, 2017$0.37$0.36$0.36 - $0.36+2.78%Beat-2.6%1N/AAug 2, 2017$37.89M
    Mar 31, 2017$0.30$0.23N/A+30.43%Beat+100.0%N/AN/AMay 3, 2017$37.05M
    Dec 31, 2016$0.20$0.23N/A-13.04%Miss-13.0%N/AN/AMar 2, 2017$36.51M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $9.80, up 17.1% from the year before. It was $0.95 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$9.80+17.1%
    Dec 31, 2024$8.37+35.7%
    Dec 31, 2023$6.17+83.1%
    Dec 31, 2022$3.37+60.5%
    Dec 31, 2021$2.10+16.0%
    Dec 31, 2020$1.81-31.4%
    Dec 31, 2019$2.64+36.8%
    Dec 31, 2018$1.93+52.0%
    Dec 31, 2017$1.27+33.7%
    Dec 31, 2016$0.95N/A

    Earnings Calls

    The 7 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 2,500 words across 7 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20262,5157
    2026Q2Jun 30, 20262,6807
    2026Q1Mar 31, 20262,8846
    2025Q4Dec 31, 20253,4797
    2025Q3Sep 30, 20253,7048
    2025Q2Jun 30, 20253,5027
    2025Q1Mar 31, 20254,2657

    2026Q3 Earnings Call

    Opening remarks

    Ronald Lataille Senior Vice President, Treasurer and CFO Thank you, operator. Good morning, and thank you for joining us on our 2026 third quarter earnings conference call. With me on today's call is our CEO, Mitch Rock. Today, we will make some forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, the accuracy of which is subject to risks and uncertainties. Wherever possible, we will try to identify those forward-looking statements by using words such as believe, expect, anticipate, pursue, forecast, and similar expressions. Our forward-looking statements are based on our estimates and assumptions as of today and should not be relied upon as representing our estimates or views on any subsequent date. Please refer to the cautionary statement regarding forward-looking information and the risk factors in our most recent 10-K and 10-Qs, including disclosure of the factors that could cause results to differ materially from those expressed or implied. During this call, we will discuss non-GAAP financial measures, which include organic sales growth, adjusted gross margin, adjusted operating income, adjusted SG&A, adjusted EPS, EBITDA, and adjusted EBITDA. A reconciliation of GAAP to non-GAAP measures discussed in this call is contained in the associated press release and is available in the Investor Relations section of our website. I'll now turn the call over to Mitch.

    Mitchell Rock CEO Thank you, Ron. Good morning, everyone, and thank you for joining us. Our third quarter reflects solid execution across UFP and steady progress on our long-term growth strategy. Third quarter sales were $172.4 million, up 11.6%. Organic growth was 11.1%. Gross margin increased to 29.4%, adjusted operating income grew 14.5%, and adjusted earnings per share increased to $2.88. Year-to-date, sales are up 10.3%, to $500.6 million. MedTech grew 11.7%, and our top five MedTech customers collectively also grew 11.7%. What stands out to me is how broad the growth is. MedTech sales were up 12.5% in the quarter, with demand across the portfolio. One of the real strengths of UFP is that our growth does not depend on any single customer, program, or end market. We were proud to be recognized by one of our top five customers with a supplier award for creating value through innovation and cost savings. That's exactly what we're aiming for: line up with where our customers are going long term and help them scale while taking costs out. On operations, we are continuing to make progress. We are scaling new programs in the Dominican Republic. Margins are improving in our legacy UFP operations. And at AJR, we have made significant year-over-year progress, both in the U.S. and in the Dominican Republic. That said, we're behind schedule moving AJR activity to the Dominican Republic.

    Frequently Asked Questions About UFPT

    When is UFP Technologies's next earnings date?

    UFP Technologies's next earnings report is expected for Feb 22, 2027.

    Did UFPT beat earnings estimates last quarter?

    Yes. UFP Technologies reported EPS of $2.88 for the quarter ended Sep 30, 2026, above the $2.63 estimate, a 9.51% surprise.

    What EPS do analysts expect from UFPT next quarter?

    The consensus EPS estimate for UFP Technologies for the quarter ending Dec 31, 2026 is $2.57 from 6 analysts, with estimates from $2.42 to $2.72.

    How often does UFPT beat earnings estimates?

    UFP Technologies beat the EPS estimate in each of the last 17 quarters, with an average surprise of +18.14%.